These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 27007835

  • 1. Minimal clinical important difference (MCID) of the Thai Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kulthanan K, Chularojanamontri L, Tuchinda P, Rujitharanawong C, Baiardini I, Braido F.
    Asian Pac J Allergy Immunol; 2016 Jun; 34(2):137-45. PubMed ID: 27007835
    [Abstract] [Full Text] [Related]

  • 2. Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Kessel A, Graif Y, Vadasz Z, Schichter-Konfino V, Almog M, Cohen S, Teplitski V, Stein N, Baiardini I, Maurer M, Toubi E.
    Isr Med Assoc J; 2016 Aug; 18(8):461-465. PubMed ID: 28471576
    [Abstract] [Full Text] [Related]

  • 3. The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.
    Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Dabbaghzade A, Tavakol Z, Afarideh M, Rezaei N.
    Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):278-85. PubMed ID: 24659164
    [Abstract] [Full Text] [Related]

  • 4. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
    Kocatürk E, Weller K, Martus P, Aktas S, Kavala M, Sarigul S, Baiardini I, Canonica GW, Brzoza Z, Kalogeromitros D, Maurer M.
    Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
    [Abstract] [Full Text] [Related]

  • 5. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).
    Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, del Cuvillo A, Montoro J, Mullol J, Sastre J, Canonica GW, Baiardini I.
    J Investig Allergol Clin Immunol; 2008 Jul; 18(6):426-32. PubMed ID: 19123433
    [Abstract] [Full Text] [Related]

  • 6. Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT).
    Kulthanan K, Chularojanamontri L, Tuchinda P, Rujitharanawong C, Maurer M, Weller K.
    Health Qual Life Outcomes; 2016 Apr 14; 14():61. PubMed ID: 27075142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.
    Dias GA, Pires GV, Valle SO, França AT, Papi JA, Dortas SD, Levy SA, Baiardini I, Canonica GW.
    Allergy; 2011 Nov 14; 66(11):1487-93. PubMed ID: 21899558
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
    Koti I, Weller K, Makris M, Tiligada E, Psaltopoulou T, Papageorgiou C, Baiardini I, Panagiotakos D, Braido F, Maurer M.
    Dermatology; 2013 Nov 14; 226(4):371-9. PubMed ID: 23942323
    [Abstract] [Full Text] [Related]

  • 13. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study).
    Jauregui I, Gimenez-Arnau A, Bartra J, Labrador-Horrillo M, de Frutos JO, Silvestre JF, Sastre J, Velasco M, Ferrer M, Ballesteros C, Valero A.
    Health Qual Life Outcomes; 2019 Jan 31; 17(1):23. PubMed ID: 30704532
    [Abstract] [Full Text] [Related]

  • 14. The validity and reliability of the Thai-version of 5-D itch scale.
    Tuchinda P, Kulthanan K, Chularojanamontri L, Rujitharanawong C, Subchookul C, Trakanwittayarak S.
    Asian Pac J Allergy Immunol; 2022 Sep 31; 40(3):254-262. PubMed ID: 32247306
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change.
    Kulthanan K, Chularojanamontri L, Rujitharanawong C, Weerasubpong P, Maurer M, Weller K.
    Health Qual Life Outcomes; 2019 Oct 26; 17(1):160. PubMed ID: 31655579
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the Reliability and Validity of the Persian Version of Urticaria Control Test (UCT).
    Khoshkhui M, Weller K, Fadaee J, Maurer M, Jabbari Azad F, Emadzadeh M.
    Iran J Allergy Asthma Immunol; 2021 Aug 07; 20(4):423-431. PubMed ID: 34418896
    [Abstract] [Full Text] [Related]

  • 20. Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice.
    Baiardini I, Braido F, Molinengo G, Caminati M, Costantino M, Cristaudo A, Crivellaro M, Ferrucci SM, Gallo R, Giorgis V, Legori A, Loera B, Martignago I, Marzano AV, Morrone A, Parente R, Parodi A, Parolo A, Peveri S, Pigatto P, Radice A, Ridolo E, Rolla G, Roncallo C, Rossi O, Savi E, Senna G, Triggiani M, Canonica GW.
    J Allergy Clin Immunol Pract; 2018 Aug 07; 6(1):208-218. PubMed ID: 28803183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.